Avalon globocare corp. (AVCO)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
REVENUES
Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Real property rental

296

360

264

264

266

273

272

278

296

291

315

222

0

0

0

0

0

-

-

-

-

-

-

-

-

Medical related consulting services - related party

-

121

108

111

14

-

71

141

-

-

2

152

-

-

-

-

-

-

-

-

-

-

-

-

-

Medical related consulting services - related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

326

0

-

-

-

-

-

-

-

-

-

Medical related consulting services - related party

-

-

-

-

-

-

-

-

-

-

-

-

66

-

-

-

-

-

-

-

-

-

-

-

-

Development services and sales of developed products

-

-2

10

23

3

15

69

75

11

26

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Total Revenues

296

479

383

399

284

344

413

496

307

319

317

374

66

289

326

0

0

-

-

0

0

0

0

0

0

COSTS AND EXPENSES
Real property operating expenses

254

201

193

192

230

196

190

195

210

199

180

161

0

-

0

0

-

-

-

-

-

-

-

-

-

Medical related consulting services - related party

-

81

94

95

13

-

64

124

-

0

47

125

99

-

33

0

-

-

-

-

-

-

-

-

-

Development services and sales of developed products

-

-0

41

31

30

31

40

42

16

15

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Total Costs and Expenses

254

282

329

319

274

289

295

362

226

215

227

287

99

-

33

0

-

-

-

-

-

-

-

-

-

REAL PROPERTY OPERATING INCOME

-42

-

-

-

-35

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

REAL PROPERTY OPERATING INCOME

-

-

-70

-72

-

-76

-81

-82

-86

-91

-134

-60

0

-

0

0

-

-

-

-

-

-

-

-

-

GROSS PROFIT FROM MEDICAL RELATED CONSULTING SERVICES

-

-

-

-

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

GROSS LOSS FROM DEVELOPMENT SERVICES AND SALES OF DEVELOPED PRODUCTS

-

-1

-31

-8

-27

-15

29

33

-5

11

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Cost of revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Cost of revenue - related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Total Cost of Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Total Gross Profit

42

360

-14

-16

10

-

-7

-17

-

65

44

-27

-33

-836

293

0

0

-

-

-

-

-

-

-

-

OTHER OPERATING EXPENSES:
Professional fees

1,553

-

-

792

1,468

-

-

593

571

467

186

172

207

234

84

41

36

-

-

-

-

-

-

-

-

Selling expenses

-

-

-

-

-

-

-

-

-

0

0

6

8

6

0

0

0

-

-

-

-

-

-

-

-

Advertising expenses

-

-

-

221

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Compensation and related benefits

1,128

2,355

2,187

2,100

2,100

1,119

569

487

538

433

468

205

182

-

0

0

-

-

-

-

-

-

-

-

-

Research and development expenses

275

414

265

949

152

-

1

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other general and administrative

307

5,000

2,066

360

754

2,787

1,926

265

285

219

92

91

60

24

1

5

23

-

-

-

-

-

-

-

-

Impairment loss

-

-

1,010

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

REVENUE

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

GENERAL AND ADMINISTRATIVE EXPENSES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

12

4

7

0

3

0

0

Total Other Operating Expenses

3,264

5,288

5,529

4,423

4,475

2,779

2,497

1,346

1,395

2,442

747

476

459

275

85

46

59

90

12

4

7

0

3

0

0

LOSS FROM OPERATIONS

-3,222

-5,091

-5,476

-4,343

-4,465

-2,723

-2,379

-1,213

-1,314

-2,338

-657

-388

-492

-25

207

-46

-59

-90

-12

-4

-7

0

-3

0

0

OTHER INCOME (EXPENSE)
Interest income

-

-

-

0

-

-

-

1

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

Interest expense

-

-3

2

8

25

27

25

24

236

43

52

42

0

-

0

0

-

-

-

-

-

-

-

-

-

Interest expense - related party

42

25

8

12

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrants liabilities

-

-

1,160

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrants liability

-

-

-

-461

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing expense

-

-

-

-525

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from equity-method investment

-9

-7

-25

-10

-12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency transaction gain (loss)

-

-

16

-

-

-

-

-106

-

0

0

0

-57

0

0

0

0

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Other income

2

-0

2

0

0

51

1

0

0

-

0

0

-56

0

0

0

0

-

-

-

-

-

-

-

-

Total Other Expense, net

-48

299

1,142

-95

-39

-30

-23

-130

-236

-

-52

-41

-

-

-

-

-

-

-

-

-

-

-

-

-

LOSS BEFORE INCOME TAXES

-3,270

-4,792

-4,334

-4,438

-4,504

-2,754

-2,403

-1,343

-1,550

-2,359

-710

-430

-549

-

-

-

-

-

-

-

-

-

-

-

-

(LOSS) INCOME BEFORE INCOME TAXES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

207

-46

-59

-

-

-

-

-

-

-

-

OTHER INCOME (EXPENSE)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

-

Other Income (Expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

INCOME TAXES

-

-

-

-

-

-

-

-

-

-

0

0

0

21

0

0

0

0

0

0

0

0

0

0

0

NET LOSS

-3,270

-4,792

-4,334

-4,438

-4,504

-2,754

-2,403

-1,343

-1,550

-

-710

-430

-

-46

207

-46

-59

-90

-12

-4

-7

0

-3

0

0

LESS: NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST

-

-

-475

-81

-99

-100

-58

-49

-69

-585

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS

-3,270

-5,448

-3,858

-4,357

-4,405

-2,653

-2,344

-1,294

-1,481

-1,773

-710

-430

-549

-

-

-

-

-

-

-

-

-

-

-

-

COMPREHENSIVE LOSS:
NET LOSS

-3,270

-4,792

-4,334

-4,438

-4,504

-2,754

-2,403

-1,343

-1,550

-2,359

-710

-430

-549

-46

207

-46

-59

-

-

-

-

-

-

-

-

OTHER COMPREHENSIVE (LOSS) INCOME
Unrealized foreign currency translation (loss) gain

-22

39

-69

-34

43

-6

-94

-96

52

28

6

7

-39

-94

0

0

0

-

-

-

-

-

-

-

-

COMPREHENSIVE LOSS

-3,292

-4,753

-4,403

-4,472

-4,461

-2,760

-2,497

-1,440

-1,498

-2,330

-704

-422

-589

-141

208

-45

-59

-

-

-

-

-

-

-

-

LESS: COMPREHENSIVE LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST

-

-

-471

-79

-100

-99

-58

-49

-69

-585

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS

-3,292

-5,404

-3,932

-4,393

-4,361

-2,661

-2,438

-1,390

-1,428

-1,745

-704

-422

-589

-

-

-

-

-

-

-

-

-

-

-

-

NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS:
Basic and diluted

-0.04

-0.07

-0.05

-0.06

-0.06

-0.04

-0.03

-0.02

-0.02

-0.02

-0.01

-0.01

-0.01

-0.00

0.00

-0.00

-0.00

0.00

-0.01

-

-

-

-

-

-

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
(Loss) per common share - Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

0.00

0.00

0.00

0.00

Basic and diluted

76,712

75,928

75,665

75,183

73,690

73,681

72,573

71,979

69,781

68,281

64,628

64,628

62,595

54,557

50,000

50,000

50,000

98,500

1,500

6,000

6,000

12,000

0

0

0